FDA Inspection
InfoRLife SAInfoRLife SA – FDA Inspection, May 3, 2024
Record Details
This FDA Inspection record concerns InfoRLife SA, with an inspection on May 3, 2024, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · c04b82e5-e12a-421a-a655-5605d083d0da
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1239106
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of InfoRLife SA
5| Date | Classification | Office | Project area |
|---|---|---|---|
| September 10, 2019 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 23, 2018 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 16, 2016 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 4, 2013 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 5, 2011 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for InfoRLife SA
- FDA Inspection 1107436 - 2019-09-10
- FDA Inspection 1044861 - 2018-02-23
- FDA Inspection 989892 - 2016-08-16
- FDA Inspection 841082 - 2013-07-04
- FDA Inspection 719827 - 2011-04-05
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.